Clinical Trials Logo
  1. Home
  2. Healthy Volunteers
  3. NCT03979235
  4. Details
NCT03979235 Clinical Trial

Developing Effectiveness Evaluation and Therapeutic Programs of Rehabilitation

Healthy Volunteers Clinical Trial

Official title:
Developing Clinic-oriented Quantitative Effectiveness Evaluation and Individualized Therapeutic Programs of Rehabilitation

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT03979235
Other study ID # 20180104
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 5, 2019
Est. completion date December 2026

Study information
Verified date January 2024
Source National Research Center for Rehabilitation Technical Aids
Contact LT Wang, PhD
Phone 86-10-58122882
Email suhonglun@nrcrta.cn
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Using robotics, sensors, and sEMG to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation

Description:

Using robotics, sensors, sEMG or other methods to develop clinic-oriented quantitative effectiveness evaluation and individualized programs of rehabilitation

Recruitment information / eligibility
Status Recruiting
Enrollment 40
Est. completion date December 2026
Est. primary completion date December 2026
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 80 Years
Eligibility Inclusion Criteria (for healthy people): - no history of psychological/psychotic problems, no history of important diseases. Exclusion Criteria (for healthy people): - history of psychological/psychotic problems Inclusion Criteria (for patients with motor deficits or dysphagia): - patients with motor function impairment such as post stroke hemiplegia. Exclusion Criteria (for patients with motor deficits or dysphagia): - cognitively or physically unable to cooperate with the examiner to finish the test

Study Design

Related Conditions & MeSH terms

Intervention

Diagnostic Test:
• Motor function assessment
perform motor function assessment by using scales, sEMG, and inertia sensors

Locations
Country Name City State
China National Research Center for Rehabilitation Technical Aids Beijing

Sponsors (1)
Lead Sponsor Collaborator
National Research Center for Rehabilitation Technical Aids

Country where clinical trial is conducted

China, 

Outcome
Type Measure Description Time frame Safety issue
Primary Motor function assessment Fugl-Meyer Assessment Change from Baseline scores at 1 month
Secondary surface EMG high-density surface EMG Change from Baseline status at 1 month
Secondary Kinematics test Using inertia sensors to assess kinematics during movement Change from Baseline status at 1 month
See also
  Status Clinical Trial Phase
Completed NCT05029518 - 3-Way Crossover Study to Compare the PK (Pharmokinetics) and to Evaluate the Effect of Food on the Bioavailability Phase 1
Completed NCT05001152 - Taste Assessment of Ozanimod Phase 1
Completed NCT04493255 - A Study to Determine the Metabolism and Elimination of [14C]E7090 in Healthy Male Participants Phase 1
Completed NCT03457649 - IV Dose Study to Assess the Safety, Tolerability, PK, PD and Immunogenicity of ARGX-113 in Healthy Volunteers Phase 1
Completed NCT00995891 - Collection of Blood, Bone Marrow, and Buccal Mucosa Samples From Healthy Volunteers for Center for Human Immunology, Autoimmunity, and Inflammatory Diseases (CHI) Laboratory Research Studies
Completed NCT05050318 - Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively Phase 4
Completed NCT05043766 - Evaluation of Oral PF614 Relative to OxyContin Phase 1
Completed NCT04466748 - A Multiple Ascending Dose Pharmacology Study of Anaprazole in Healthy Chinese Subjects Phase 1
Completed NCT00746733 - Vyvanse and Adderall XR Given Alone and in Combination With Prilosec OTC Phase 1
Recruiting NCT05929651 - Study of Immunogenicity and Safety of MenQuadfi® as a Booster Vaccine in Toddlers 12 to 23 Months, Regardless of the Quadrivalent Meningococcal Conjugate Vaccine Used for Priming in Infancy Phase 4
Completed NCT05954039 - Evaluation of the Efficacy of a Dietary Supplement on Hair Loss and Hair Aspect N/A
Completed NCT05045716 - A Study of Subcutaneous Lecanemab in Healthy Participants Phase 1
Active, not recruiting NCT02747927 - Efficacy, Safety and Immunogenicity of Takeda's Tetravalent Dengue Vaccine (TDV) in Healthy Children Phase 3
Completed NCT05533801 - A Study to Demonstrate the Bioequivalence of Lecanemab Supplied in Vials and a Single-Use Auto-Injector (AI) in Healthy Participants Phase 1
Not yet recruiting NCT03931369 - Adaptation of Thirst to a Single Administration of Tolvaptan (TOLVATHIRST) Phase 2
Completed NCT03279146 - A Single Dose Study Evaluating PK of TXL Oral Formulations in Healthy Subjects Phase 1
Completed NCT06027437 - A Study to Assess the Relative Biological Availability and the Effect of Food on the Drug Levels of Danicamtiv in Healthy Adult Participants Phase 1
Recruiting NCT05619874 - Effects of Two Virtual HIFCT Programs in Adults With Abdominal Obesity N/A
Completed NCT05553418 - Investigational On-body Injector Clinical Study N/A
Completed NCT04092712 - Study Evaluating Pharmacokinetics and Mass Balance of [14C]-CTP-543 in Healthy Adult Male Volunteers Phase 1